Number of cells and differential labeling

Number of cells and differential labeling. As the total number of embryonic cells decreases, the developmental potential of preimplantation mammalian embryos decreases. Compared with that after control antibody treatments, the total number of cells (mean + SE) in in vivo-derived embryos was significantly (P < 0.05) less after treatment with neutralizing antibodies to EGF (68.8 + 0.9 cells), TGFa (67.8 + 1.6 cells), and EGFR (68.0 + 2.2 cells) and combined treatment with antibodies to both EGF and TGFa (59.4 + 0.7 cells; Table 3 and Figure 1 A, D, and G). Similar relative results were observed after treatment of in vitro-fertilized embryos with neutralizing antibodies to EGF (63.8 + 0.7 cells), TGFa (63.0 + 1.2 cells), and EGFR (63.6 + 1.3 cells) and combined treatment with antibodies to both EGF and TGFa (57.4 + 0.5). Cell size was decreased after immunoneutralization treatment (Figure 1 D).

Further, after combined antibody treatment, the percentage of total number of cells in in vivo-derived (77%) and in vitro-fertilized (77%) embryos was no different from that in ICNI-derived embryos (78%; Table 3, Figure 1 G). Your treatment should cost you as much as you are ready to pay and my canadian pharmacy corp is doing its best to ensure competitive prices. We cooperate with largest manufacturers of high quality drugs, so you are always welcome to place an order with us, getting the amount of medicine you need with delivery as fast as you request.

Table 3. Total number and percentage (mean ± SE) of cells in in vivo-derived, in vitro-derived, and ICNI-derived (cloned) embryos after treatment with neutralizing antibodies to EGF, TGFa, and EGF-R; combined treatment with EGF and TGFa; and negative (no antibody) and positive (anti-KLH) control treatments

Values with different alphanumeric superscripts are significantly (P < 0.05) different.

Table 4. ICM:TE ratios (mean ± SE) in in vivo-derived, in vitro-derived, and ICNI-derived (cloned) embryos after treatment with neutralizing antibodies to EGF, TGFa, and EGF-R; combined treatment with EGF and TGFa; and negative (no antibody) and positive (anti-KLH) control treatments

Values with different alphanumeric superscripts are significantly (P < 0.05) different.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s